Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Mammogram findings linked to heightened risk of CVD, type 2 diabetes and hypertension
The new research, presented during ARRS 2024 in Boston, suggests CVD risk models may need to include certain findings identified in routine mammograms.
$Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow$
AI-based CAD assessments dramatically improve vascular surgery outcomes
PAD patients evaluated with HeartFlow's noninvasive FFR_CTAnalysis technology prior to surgery experienced much better outcomes, including a 63% lower risk of all-cause mortality after five years.
Incidental breast calcifications on mammograms linked to much higher risk of cardiovascular disease
These findings may say a lot more about a patient's long-term health than clinicians realized.
$HeartFlow FFR-CT is a non-invasive imaging method to determine the fractional flow reserve for the entire coronary tree.$
AI-based CAD assessments as accurate as FFR, new 10-year study confirms
The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab.
Coronary calcium scoring predicts when chest pain patients can skip invasive testing
Using CT to perform coronary artery calcium scoring on symptomatic chest pain patients can deliver significant value, according to a new data published in Radiology.

Mammogram findings linked to heightened risk of CVD, type 2 diabetes and hypertension

The new research, presented during ARRS 2024 in Boston, suggests CVD risk models may need to include certain findings identified in routine mammograms.

May 14, 2024

$Performing CT-derived fractional flow reserve (CT-FFR) before transcatheter aortic valve replacement (TAVR) improves the accuracy of coronary CT angiography (CCTA) and helps limit unneeded invasive coronary angiography (ICA), according to a new study published in JACC: Cardiovascular Interventions. Heartflow$

AI-based CAD assessments dramatically improve vascular surgery outcomes

PAD patients evaluated with HeartFlow's noninvasive FFR_CTAnalysis technology prior to surgery experienced much better outcomes, including a 63% lower risk of all-cause mortality after five years.

May 14, 2024

Breast arterial calcifications (BACs) identified on screening mammograms may help identify women who face a heightened risk of developing cardiovascular disease (CVD), according to a new analysis published in Clinical Imaging.

Incidental breast calcifications on mammograms linked to much higher risk of cardiovascular disease

These findings may say a lot more about a patient's long-term health than clinicians realized.

March 18, 2024

$HeartFlow FFR-CT is a non-invasive imaging method to determine the fractional flow reserve for the entire coronary tree.$

AI-based CAD assessments as accurate as FFR, new 10-year study confirms

The FDA-approved technology developed by HeartFlow can predict a patient's long-term risk of target vessel failure as well as more invasive treatments performed inside a cath lab.

March 12, 2024

Using computed tomography (CT) to perform coronary artery calcium (CAC) scoring can help identify symptomatic chest pain patients who do not require further testing, according to a new analysis published in Radiology.[1]

Coronary calcium scoring predicts when chest pain patients can skip invasive testing

Using CT to perform coronary artery calcium scoring on symptomatic chest pain patients can deliver significant value, according to a new data published in Radiology.

March 6, 2024

Cardiologists partner with imaging AI specialists to improve care for high-risk heart patients

The new collaboration is designed to ensure patients who may face an increased risk of heart disease receive the follow-up care they need.

February 29, 2024

artificial intelligence AI heart cardiology

Cleerly’s AI software for noninvasive FFR estimates receives a Category 1 CPT code

The company officially launched its Cleerly ISCHEMIA software for delivering noninvasive evaluations of CCTA exams in early 2024. This update provides a closer look at the software from a billing perspective.

February 23, 2024

HeartFlow’s AI-powered CAD offering reaches a significant milestone

The company's trademark offering has now been used to evaluate one quarter of a million patients.

January 3, 2024

Around the web

Cardiovascular Business

AI improves CT assessments, boosts care for real-world heart patients

Automated AI-generated measurements combined with annotated CT images can improve treatment planning and help referring physicians and patients better understand their disease, explained Sarah Jane Rinehart, MD, director of cardiac imaging with Charleston Area Medical Center.

Cardiovascular Business

AI predicts cardiovascular risk during CT scans—no invasive tests or contrast required

Two advanced algorithms—one for CAC scores and another for segmenting cardiac chamber volumes—outperformed radiologists when assessing low-dose chest CT scans.

Radiology Business

Google teams with Bayer to address radiologist burnout via AI

"Gen AI can help tackle repetitive tasks and provide insights into massive datasets, saving valuable time," Thomas Kurian, CEO of Google Cloud, said Tuesday.